Janssen Pharmaceutica Nv

Galapagos Nv

Biofocus Dpi, Ltd.

Angus MacLeod

Mark Stuart Chambers

Martin James Inglis Andrews

Wolfgang Schmidt

Kim Louise Hirst

Juha Andrew Clase

Paul John Edwards

Gregory Bar

Clifford John Harris

Philip Huxley

Veronique Birault

Reginald Christophe Xavier Brys

Christophe Parsy

Dale Robert Mitchell

Nicholas John Palmer

Michael Daniel Goldsmith

Christophe Claude Parsy

Paul Edwards

Novel imidazopyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a viral infection, in particular a HCV, HRV, Sb and/or CVB in a patient in need thereof.

Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following:  The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Novel imidazo[-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.

Growing community of inventors

Saffron Walden, United Kingdom

Angus MacLeod